A.R.T. Advisors’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
Sell
-30,286
Closed -$381K 1775
2013
Q3
$381K Buy
+30,286
New +$401K 0.02% 881

A.R.T. Advisors's OPTR Position: Q4 2013 in Review

A.R.T. Advisors sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 30,286 shares — an estimated $381K sold.

A.R.T. Advisors first reported a position in OPTR in Q3 2013 and held it in 1 quarter. The position peaked at $381K in Q3 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • A.R.T. Advisors reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • A.R.T. Advisors sold 30,286 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $381K.
  • A.R.T. Advisors first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q3 2013 and held it in 1 quarter.
  • A.R.T. Advisors's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $381K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on A.R.T. Advisors's 13F filing for Q4 2013, filed 14 Feb 2014.